Clinical trial · Observational
Study on the Occurrence of Head and Neck Cancers During Pregnancy
NCT03738267CI-TRIAL-00095879REFCORbirthsuspendedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): number of inclusions not reached
Summary
Brief summary (as posted)
Head and neck cancers that occurred during pregnancy
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Pregnancy Related | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (4)
- measure
- Serological status of patients
- timeFrame
- Through study completion, an average of 5 years
- description
- Number of patients with positive or negative serological status for PVH (Papilloma Virus Humain) and EBV (Epstein-Barr Virus)
- measure
- Characteristics pregnancy of patients
- timeFrame
- Through study completion, an average of 5 years
- description
- Presence or absence of maternal-fetal diseases
- measure
- Tumor characteristics of patients
- timeFrame
- Through study completion, an average of 5 years
- description
- Histological type of cancer
- measure
- Tumor characteristics of patients
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 year old woman or over at the time of participation * PS 0 -2 * Cancer diagnosed (biopsy date) from 01/01/2010 between the second week of pregnancy and the 12 months postpartum. * Primitive may concern the following sites: oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, prevalent lymphadenopathy, nasal cavity, salivary glands, dental tumors, ear tumors, paragangliomas optic pathways, facial sinus / facial mass, nose, ear and other head and neck * All histologies (epithelial tumors, sarcomas, mucosal melanomas, embryonic tumors, undifferentiated tumors) * Patient receiving or having received a specific oncological treatment among surgery, radiotherapy, chemotherapy, hormone therapy. * All stages allowed: localized stages and metastatic stages immediately. * No opposition of the patient to participate in this study Exclusion Criteria: * Any other neoplastic antecedent * Exclusion of metastases at the level of the VADS of another primitive than a cancer of the VADS * Exclusion of hematological tumors (lymphoma) and glial tumors * Person subject to a legal protection measure or unable to express their consent
References
Publications (0)
Data not yet available
No reference posted for this study.